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ABSTRACT: Over two hundred species of plants can be
infected by the phytopathogenic fungus Botrytis cinerea under a
range of diﬀerent environmental conditions. In response to
these, the fungus produces unique terpenoid and polyketide
metabolites. Parts of the plants may be killed by the phytotoxin
botrydial, enabling the fungus to feed on the dead cells. In this
paper, we describe the genetic and molecular basis of botrydial
biosynthesis and the function of the ﬁve genes of the genome
of B. cinerea that together constitute the botrydial biosynthetic
gene cluster. Genes BcBOT3 and BcBOT4, encoding two
cytochrome P450 monooxygenases, were inactivated by
homologous recombination and were shown to catalyze
regio- and stereospeciﬁc hydroxylations at the carbons C-10
and C-4, respectively, of the presilphiperfolan-8β-ol skeleton. The null mutants, bcbot3Δ and bcbot4Δ, accumulated key
intermediates in the botrydial biosynthesis enabling the complete genetic and molecular basis of the botrydial biosynthetic
pathway to be established. Furthermore, the bcbot4Δ mutant overproduced a signiﬁcant number of polyketides, which included,
in addition to known botcinins, botrylactones and cinbotolide A, two new botrylactones and two new cinbotolides, cinbotolides
B and C.
Fungal secondary metabolites have a wide impact on humanhealth, medicine, and agriculture. While many secondary
metabolites including antibiotics, immunosuppressants, and
phytohormones are beneﬁcial, other such as phytotoxins and
mycotoxins are harmful to plants, humans, and animals.1 In
order to manage or modify the biosynthesis of secondary
metabolites, we need to identify the location of the genes
encoding the relevant biosynthetic enzymes. The genes that
encode the biosynthesis of structurally related secondary
metabolites are often clustered. The horizontal gene transfer
(HGT)2 between distant fungi may be facilitated by such
clustering, conferring an evolutionary advantage.3−6
The Ascomycete Botrytis cinerea is the cause of “gray mold”
disease of a wide range of dicoyledons under a variety of
environmental conditions in which its secondary metabolites
(SM) confer a selective advantage. B. cinerea has the
characteristics of a necrotroph in which the infection may be
mediated by the production of phytotoxins and reactive oxygen
species, as well as by inducing an oxidative burst in the plant.7,8
A number of unique terpenoids and polyketides have been
obtained from the mycelium. These include two groups of
nonspeciﬁc phytotoxins. The ﬁrst are the sesquiterpenoid
botryanes,9 botrydial (1) and dihydrobotrydial (2). The second
are the polyketide lactones, botrylactone (3)10 together with
botcinic (4) and botcineric acid (5),11 and their cyclic relatives,
the botcinins (6, 7).12 Cinbotolide (8) is a new polyketide that
has been reported and contains a carbon chain that possesses
structural features and a stereochemistry reminiscent of the
botcinins and botrylactone (Figure 1).13
Botrydial (1) is the major phytotoxin14,15 of B. cinerea, and it
has been shown to reproduce the symptoms of the
infection.16,17 Spectroscopic, chemical, and X-ray methods18−20
were used to establish the irregular sesquiterpenoid structures
of these botryane metabolites. Their biosynthesis via farnesyl
diphosphate (FPP, Figure 2) has been elucidated.21−24
The genome of B. cinerea has been sequenced leading to the
identiﬁcation of the genes that are responsible for the synthesis
of its secondary metabolites. Forty-four genes that encode key
enzymes (KE) that are responsible for the committed
biosynthetic steps were identiﬁed from sequences in two
strains, BO5.10 (B cero ﬁve.ten) and T4.25,26 Typical of the
secondary metabolism of ﬁlamentous fungi, the majority of the
genes that encode these key enzymes are part of biosynthetic
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gene clusters. Among them, the botrydial biosynthetic gene
cluster has been identiﬁed (Figure 3).27,28 The cluster, which
consists of ﬁve genes (BcBOT1 to BcBOT5) (for Botrytis cinerea
BOTrydial) involves one gene coding for a sesquiterpene
cyclase (BcBOT2), three monooxygenases (BcBOT1, BcBOT3,
and BcBOT4), and an acetyl transferase (BcBOT5).
Gene deactivation studies, which had been carried out
previously, had shown that the BcBOT1 gene, encoding a P450
monooxygenase is responsible for one of the ﬁnal steps in
botrydial biosynthesis,27 while BcBOT2 codes for a sesquiter-
pene cyclase (presilphiperfolan-8β-ol (PSP) synthase),28 which
is an early step in botrydial biosynthesis (Figure 2).
Figure 1. Some metabolites isolated from Botrytis cinerea.
Figure 2. Biosynthetic pathway to botrydial (1).
Figure 3. Scheme of the gene cluster involved in the biosynthesis of
botrydial. Dashed line indicates AT-rich DNA (more than 80% of A
and T content).
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The P450 monooxygenases, under mild reaction conditions,
catalyze regio- and stereospeciﬁc oxidations of nonactivated
hydrocarbons, to yield interesting chemical transformations in
biosynthetic chemistry.29
This paper describes the molecular sequence of botrydial
biosynthesis and the functions of the three cytochrome P450
monooxygenases involved in botrydial biosynthesis in terms of
the hydroxylations at C-4, C-10, and C-15 on the PSP carbon
skeleton. The structures of four new polyketide metabolites,
which were isolated from the bcbot4Δ mutant, are also
reported.
■ RESULTS AND DISCUSSION
Previous experiments using isotopically labeled acetate and
mevalonate established the origin of the carbon skeleton of
botrydial (1) and the occurrence of a backbone rearrangement
and 1,3-hydride shift during the cyclization of FPP.9,24,30 The
original mechanistic proposal (Figure 2) has been corroborated
by the incubation of labeled FPP with a recombinant PSP
synthase (BcBOT2) to aﬀord the labeled intermediate tricyclic
alcohol, presilphiperfolan-8β-ol (2a, PSP, probotryane).31 This
intermediate 2a is converted to botrydial (1) by the action of
the three cytochrome P450s encoded by the co-regulated genes
BcBOT1, BcBOT3, and BcBOT4 together with the acetyl-
transferase (BcBOT5), which function in an as yet unknown
sequence.
Deletion of the Genes Encoding BcBOT3 and BcBOT4
Monooxygenases. Previous studies of the amino acid
sequences of the BcBOT3 and BcBOT4 proteins have revealed
the presence of conserved P450 monooxygenase domains,
which suggested that they could be involved in botrydial
biosynthesis.27,28 A gene knockout (KO) approach was used to
conﬁrm this hypothesis. Two KO DNA cassettes containing a
nourseothricin resistance gene in place of the BcBOT genes,
were constructed by PCR fusion and employed to transform
protoplasts of the B05.10 wild-type strains (for details, see
Methods). The transformation resulted in two independent
bcbot3Δ and two independent bcbot4Δ mutants. PCR analyses
veriﬁed integration of the replacement fragment at the targeted
loci of the genome and the absence of wild-type nuclei. Both
mutants grow and produced conidia similarly to the parent
strain B05.10 on a standard rich medium (data not shown).
Chemical Characterization of the bcbot3Δ and
bcbot4Δ Mutants. The KO bcbot3Δ and bcbot4Δ mutants,
which had been derived from the B05.10 strain, were grown on
a solid malt agar medium. The metabolites were recovered in
ethyl acetate and puriﬁed by column chromatography on silica
gel. The products were ﬁnally puriﬁed by HPLC to yield the
metabolites shown in Figure 4. The results indicated that none
of the mutants produced botrydial (1), conﬁrming that these
mutations were involved in botrydial biosynthesis.
The chromatographic study, characterization, and quantiﬁ-
cation of the metabolites biosynthesized by the bcbot3Δ mutant
showed, in addition to small amounts of botcinin A (6), high
levels, (35 mg/L), of the biosynthetic intermediate 4β-acetoxy-
15α-hydroxyprobotryane (2d), Figure 2, which was identiﬁed
by extensive NMR studies and comparison with authentic
samples. In addition, the new metabolite 9 was isolated and
characterized.
Compound 9 was obtained as colorless oil. It showed a
molecular ion in its HRMS (ESI+) at m/z = 253.1807
[(C15H25O3), M + H]
+ in agreement with the 13C NMR and
DEPT spectra. The 1H and 13C NMR spectra of compound 9
contained a similar pattern of signals to the probotryane
intermediate (2d). However, the signal for the C-4 CH(OH)
appeared at ∂ 4.04, while the signals for the acetate group and
the C-15 CH(OH) were missing. There was a signal in the 13C
NMR spectrum at ∂ 211.0 characteristic of a cyclopentanone,
while the H-10 proton resonances were shifted. These
spectroscopic data indicated that compound 9 was the
oxidation product of the biosynthetic intermediate 2d
possessing a carbonyl group at C-15. Acetylation of compound
9 yielded a monoacetylated derivative 9a that exhibited the
characteristic 1H NMR signals of a methyl group at ∂ 2.03 and a
signal, ddd, at ∂ 5.11 for the proton geminal to the acetate. The
proton and carbon-13 NMR signals of both compounds 9 and
9a were assigned by detailed analysis of their COSY, NOESY,
HSQC, and HMBC spectra (Supplementary Table S1). These
conﬁrmed their structures and relative stereochemistry.
The fermentation broth of mutant bcbot4Δ was chromato-
graphed following the same procedure used for the KO mutant
bcbot3Δ. Final puriﬁcation by HPLC and GC-MS yielded the
metabolites 2a and 3−8 (Figures 1 and 2) and 10−18 show, in
Figure 4. Interestingly, in addition to the key probotryane
intermediate 2a, from the cyclization of FPP by the
sesquiterpene cyclase BcBOT2, an overproduction of poly-
ketides was observed yielding the new polyketides 15−18,
Figure 4.
The probotryane 2a, which was accumulated by the bcbot4Δ
mutant, was identiﬁed in the hexane fraction by comparison
with an authentic sample. Although it had not been found in
Figure 4. Some metabolites isolated from mutants bcbot3Δ and
bcbot4Δ.
ACS Chemical Biology Articles
DOI: 10.1021/acschembio.6b00581
ACS Chem. Biol. 2016, 11, 2838−2846
2840
the wild-type (Figure 5A), it was readily identiﬁed in the
bcbot4Δ mutant fermentation after 4, 8, and 10 days (Figure
5B).
Chemical Characterization of Polyketides Isolated
from bcbot4Δ Mutant. The metabolites 15 and 16 showed
a pattern of NMR signals that were characteristic of the
botrylactones.11 The 13C NMR contained 22 signals indicating
that the side chain contained eight carbon atoms. The 1H NMR
of compound 15 resembled that of 14. The most signiﬁcant
diﬀerences were the multiplicity of the signals corresponding to
the double bond and the absence of the signal of a geminal
proton to a hydroxyl group in the side chain. Thus, the vinylic
proton signals appeared as doublet of triplets at ∂ 7.04, H-3′,
and a doublet corresponding to H-2′, ∂ 5.84, indicating that
compound 15 possessed a side chain that was similar to that of
compound 14 but with eight carbon atoms and without a
hydroxyl group at C-4′.
The HRMS, which was supported by the 13C NMR
spectrum, showed that compound 15 possessed a molecular
formula of C22H34O7. The COSY, HSQC and HMBC spectra,
and NOE experiments (Supplementary Table S2) led to the
structure 5-hydroxy-7-(oct-2-enoyl)botrylactone for compound
15.
Compound 16 showed 1H NMR signals that were
comparable to botrylactone (3).11 The main diﬀerences were
the lack of the signal typical of the C-7 CH(OH) while the
signal assigned to the C-6 methyl group was a singlet rather
than a doublet. The HRMS and 13C NMR spectra indicated
that the compound 16 had a molecular formula C14H22O5. All
the carbons and their associated proton signals were assigned
from an examination of the COSY, HSQC, HMBC, and
NOESY spectra (Table S3), in accord with the structure and
relative stereochemistry of compound 16. The relative
stereochemistry of the chiral center at C-6 followed from the
NOE experiments. The rigid structure of the compound meant
that a β conﬁguration of the C-6 methyl group would produce
NOE interactions with the C-4 and C-8 methyl groups
(Supplementary Figure S1), which would not be observed
Figure 5. Comparative metabolites proﬁled by GC-MS analysis, for determination of probotryane 2a in the strain broths. (A) Chromatograms of 2a
and of the extract obtained from the wild-type, B05.10 at 4, 8, and 10 days. (B) Chromatograms of 2a and of the extract obtained from the mutant
bcbot4Δ at 4, 8, and 10 days.
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with its epimer. However, irradiation of the C-4 methyl group
gave NOE interactions with H-2 and H-5β while irradiation of
the C-8 methyl signals revealed interactions with H-7β and H-
14. Furthermore, irradiation of the C-6 methyl signal only gave
NOE interactions with H-5α and H-7α indicating an α rather
than a β conﬁguration for this methyl group. These data led to
the structure and stereochemistry of 6-β-hydroxy-7-deoxybo-
trylactone for 16 (Table S3, Figure S1).
The 1H NMR signals of compound 17 resembled those of
cinbotolide A (8).13 There was one primary and one secondary
hydroxyl group and one double bond in its structure. The main
diﬀerences were the multiplicities of the −CH2OH signal and
the C-9 vinylic proton resonance. In addition to the signals
assigned to the methyl groups at C-2, C-4, C-6, and C-8, there
was a double−doublet at ∂ 5.39 (H-9) and signals at ∂ 4.15 (dd,
J = 12.0, 6.9 Hz) and 4.05 (d, J = 5.4 Hz) attributed to H-10
and H-3, respectively.
The HRMS together with the 13C NMR spectrum was
consistent with a molecular formula C14H24O4. Examination of
the HSQC, HMBC, and COSY spectra enabled all the carbons
and their associated 1H NMR signals to be assigned (Table S4).
Thus, compound 17, which was named cinbotolide B, was the
“Z” isomer of cinbotolide A (8).
The molecular formula of compound 18 was shown by
HRMS to be C14H24O5. The
13C NMR spectrum contained
signals corresponding to four methyl, three methylene, and four
methine groups, together with three quaternary carbons. The
latter included a signal at δ 177.3 ppm attributed to a lactone.
The four methyl group signals in the 1H NMR spectrum were
three doublets (δ 0.98, 1.14, and 1.26) and a singlet (δ 1.21).
The pattern of signals was typical of a cinbotolide lactone
containing two hydroxyl groups. The proposed structure 18
was consistent with the HSQC, HMBC, and COSY spectra
(Table S5). The stereochemistry was deduced from NOE
experiments. When H-3 was irradiated, there were enhance-
ments to the signals corresponding to H-2, H-11, and H-5β,
and when H-2 was irradiated there were enhancements to the
signals corresponding to H-3, H-11, and in particular H-5α.
Consequently compound 18 was a C-2 epimer (H-2α) of the
cinbotolides A and B (8 and 17). This epimerization at C-2 has
been observed in other polyketides biosynthesized by this
fungus,11 and it was supported by conformational study carried
out with molecular mechanics calculation (Figures S1 and S2).
When H-6 was irradiated, NOE eﬀects were observed at H-14,
H-12, H-5, and H-7. A NOE eﬀect on H-2 and H-5β was
observed on irradiation of H-5α, while eﬀects on H-12, H-9, H-
6, and H-10 were produced by irradiation of H-14. These
eﬀects were consistent with the structure and stereochemistry
of 18, named cinbotolide C. In this cinbotolide, epimerization
has taken place at C-2, and the C-4 methyl group (C-12) has
been oxidized and an ether bridge has been formed to C-8.
Genetic and Molecular Basis of Botrydial Biosyn-
thesis. Although the biochemical function of the enzymes
BcBOT1 and BcBOT2 is known, the functional role of the
proteins BcBOT3, BcBOT4, and BcBOT5 are still unknown. In
order to understand the molecular basis and to complete the
biosynthetic pathway to botrydial (1), the KO mutants for the
cytochrome P450 monooxygenases BcBOT3 and BcBOT4
encoding genes were constructed, and their secondary
metabolism was studied from the chemical point of view to
identify the potential biosynthetic intermediates that were
produced and to characterize both of the P450 monoox-
ygenases.
Previous studies showed that BcBOT2 protein catalyzes the
cyclization of FPP to the sesquiterpene alcohol PSP, 2a, and is
required for the production of botryane and probotryane
sesquiterpenes, which ﬁrmly established that BcBOT2 is
responsible for the initial step of the botrydial biosynthesis
(1).28,31 On the other hand, inactivation of the BcBOT1 gene
demonstrated that those mutants were unable to produce
10β,15α-dihydroxyprobotryane (2e), botrydial (1), or some of
its relatives. Instead the intermediate 2c was accumulated,
indicating that the monooxygenase BcBOT1 was responsible
for the regiospeciﬁc hydroxylation at C-15, in intermediate 2b,
to give 2d in botrydial biosynthesis, Figure 2.27
In this context, the knock out bcbot3Δ and bcbot4Δ mutants
were fermented, and their broths were examined to identify the
secondary metabolites that were produced. Compounds 2d and
9 (Figures 2 and 4) were isolated from the broth of the mutant
bcbot3Δ and characterized. The large amount of the metabolite
2d that was isolated clearly indicated that the monooxygenase
BcBOT3 is involved in the regio- and stereospeciﬁc β
hydroxylation at C-10 on the skeleton of intermediate 2b,
yielding intermediate 2c, and thus the hydroxylated derivative
at C-15, 2d, accumulated.
It was observed that the bcbot3Δ mutant did not produce
botrydial (1) and only produces small amounts of botcinin A
(6). This result was unexpected, since we had previously
established that the suppression or inhibition of the
biosynthetic pathway leading to botrydial (1) induced the
overproduction of the second family of toxins, botcinic and
botcineric acids (4, 5) and botcinins A and B (6, 7).32 These
results seem to suggest that the metabolic system of the fungus
behaved as though the production of botrydial (1) was not
inhibited, keeping the gene expression and the production of
botcinins low. This result leads us to propose that this P450
monooxygenase as a good target for controlling the fungus and
its pathogenicity by its inhibition.
The mutant bcbot4Δ accumulated the probotryane 2a in the
less polar fractions. This was established by GC-MS using an
authentic sample of 2a as reference, Figure 5. These results
showed that the monooxygenase BcBOT4 catalyzes the ﬁrst
regio- and stereospeciﬁc hydroxylation of the probotryane
skeleton 2a at C-4.
The previously reported isolation of intermediates 2b and
acetylated derivatives 2c and 2d23 led us to propose that the
acetyl transferase BcBOT5 brought about the acetylation of the
hydroxyl group at C-4 of probotryane 2b.
These results lead us to propose the complete biosynthetic
pathway to botrydial (1), Figure 2. Thus, direct and indirect
evidence for the cyclization of FPP to the parent tricyclic
alcohol 2a, by the sesquiterpene cyclase BcBOT2, has been
reported.28,31 In addition, the accumulation of intermediate
probotryanes 2a, 2c, and 2d conﬁrmed the proposed
biosynthetic sequence in which the BcBOT4 monooxygenase
produced the hydroxylation at C-4 to give intermediate 2b.
Acetylation of the hydroxyl at C-4 was carried out by the acetyl
transferase BcBOT5, followed by the combined action of the
P450 monooxygenases BcBOT3 and BcBOT1, to yield ﬁnally
the glycol 2e, via the regio- and stereospeciﬁc hydroxylations at
C-10 and C-15 of the intermediates 2c and 2d, respectively.
The cleavage of the C-10−C-15 bond of probotryane
skeleton is an intriguing and chemically important reaction,
which could be mediated by some of the monooxygenases or
by a combination of them. Many P450 monooxygenases carry
out the oxidative cleavage of vicinal diols, such as the side chain
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cleavage (scc) enzyme in testosterone biosynthesis that cleaves
the 20,22-diol.33 Although the mechanism of this cleavage has
never been settled in detail, in this case, it is possible that in the
formation of 2e, either BcBOT3 or BcBOT1 would oxidize
either the 10- or the 15-hydroxy group to the hydroperoxide
derivative, which would then undergo heterolytic fragmentation
to give the dialdehyde botrydial (1).
The products isolated from these mutants shed an interesting
light on a possible mechanism for the cleavage of the C-10−C-
15 bond in botrydial biosynthesis. Earlier studies had shown
that this takes place with the formation of botrydial rather than
dihydrobotrydial and the use of stereospeciﬁcally labeled
mevalonates implicated a trans C-10−C-15 glycol.21,22,24 The
formation of a C-15 ketone (9) when BcBOT3 is knocked-out
but BcBOT1 remains suggests that the oxidation of the C-15
alcohol to a ketone can be mediated by this enzyme. Since
BcBOT1 is a monooxygenase rather than a dehydrogenase, the
oxidation may occur by the reaction indicated in Figure 6A,
where ketone (9) is obtained, via hydroperoxide, from the
alcohol intermediate 2d.
A corollary to this suggestion is that the cleavage of the C-
10−C-15 bond is also mediated by this enzyme. This would
involve the fragmentation of a C-15 hydroperoxide derived
from 2e (Figure 6B). This would accord with the labeling
pattern from the mevalonates and in particular the trans
relationship between the functional groups.24
Here we have reported the genetic and molecular basis of
botrydial biosynthesis and the assignment of the biochemical
function to the ﬁve genes that are colocalized in the genome of
B. cinerea and constitute the botrydial biosynthesis gene cluster.
Genes BcBOT3 and BcBOT4, encoding two cytochrome P450
monooxygenases, catalyzed regio- and stereospeciﬁc hydrox-
ylations at the carbons C-10 and C-4, respectively, of the
presilphiperfolan-8β-ol skeleton. Interestingly, the bcbot4Δ
mutant overproduced a signiﬁcant number of polyketides,
which included the four new metabolites 15−18.
■ METHODS
Fungal Strains. The strain of Botrytis cinerea Pers. Fr. employed in
this work, B05.10, was isolated from a Vitis ﬁeld.34
Media and Culture Conditions. B. cinerea strains and mutants
were cultivated at 23 °C with 12 h daylight per day. Cultures were
grown on malt agar medium (MA; 20 g/L. malt extract, 5 g/L yeast
extract, 15 g/L agar) and minimal medium (MMII; 20 g/L glucose, 2
g/L NaNO3, 1 g/L KH2PO4, 500 mg/L MgSO4·7H2O, 500 mg/L KCl,
10 mg/L FeSO4·7H2O, 15 g/L agar). The transformation medium was
a minimal medium supplemented with saccharose (MMV; 20 g/L
glucose, 200 g/L saccharose, 2 g/L NaNO3, 1 g/L KH2PO4, 500 mg/L
MgSO4·7H2O, 500 mg/L KCl, 10 mg/L FeSO4·7H2O, 15 g/L agar).
The bcbot3 and bcbot4 mutants were selected with nourseothricin
fungicide (Werner Bioagent, Germany; 70 μg/mL).
Standard Molecular Methods: Gene Deletion of the
Cytochrome P450-Encoding Genes BcBOT3 and BcBOT4. The
B. cinerea genes BcBOT3 and BcBOT4 (GenBank AY277723.2) were
deleted by homologous recombination. The 5′ genomic noncoding
regions of BcBOT3 and BcBOT4 (882 bp and 1442 bp, respectively)
were ampliﬁed by PCR. In the same way, we obtained the 3′ ﬂanking
sequences of BcBOT3 and BcBOT4 (1027 bp and 866 bp, respectively)
and the nourseothricin resistance gene (nat). For each gene, a
knockout (KO) cassette made of the 5′ ﬂanking sequence of bcbot, the
nat resistance gene, and the 3′ ﬂanking region of BcBOT was obtained
by double-joint PCR fusion35 as previously described for B. cinerea.36
All the PCR primers are listed in Table 1.
Protoplasts of the B05.10 strain were transformed as previously
reported.37 Transformants were selected and puriﬁed on medium agar
containing 70 μg/mL nourseothricin. Gene inactivation was veriﬁed by
PCR using primers designed outside the KO cassette and primers
designed in the resistance gene nat (primers verif integration, Table 1).
In addition, the absence of the BcBOT3 or BcBOT4 WT alleles in the
transformant was also checked by PCR. B. cinerea mutants used in this
study are described at http://botbioger.versailles.inra.fr/botmut/.
Chemical Methods and Analysis of the bcbot3Δ and
bcbot4Δ Metabolite Proﬁle. General Procedure. B. cinerea WT
strain and mutants were grown on malt agar medium32 at 25 °C to
produce mycelium plugs (0.8 cm) that were further used to inoculate
the medium for metabolite production. All strains were fermented in
solid malt agar medium following the reported protocol.32 Extraction
of the solid agar malt medium was carried out with an ultrasonic bath,
using ethyl acetate (3 × 0.5 vol). The solvents were dried over Na2SO4
and concentrated to dryness.
Puriﬁcation of the metabolites was carried out by column
chromatography (CC) and semipreparative and analytical
HPLC.28,32 Optical rotation was recorded with a digital polarimeter.
Figure 6. (A) Formation of compound 9 from intermediate 2d. (B)
Formation of botrydial (1) from intermediate 2e.
Table 1. PCR Primers Used for BcBOT3 and BcBOT4 Gene Deletion
primer name pair sequence fwd sequence rev usage
BD48/BD51 tccattaagtctgtttggataaagt GGGAATGCGGCTCTAGTCGGGTTGCTCTTCTCCAT BcBOT3 homologuous 5′ region
BD49/BD50 gggcttgaaaagaatttgtattg cctgagcggcctgcaaaatggatcgcaacttcgtc BcBOT3 homologuous 3′ region
BD44/BD46 gcttcttgtccttccgctac GGGAATGCGGCTCTAGTTCACTTTCTCCGATTCATG BcBOT4 homologuous 5′ region
BD43/BD45 TATGACCGGAGAGCTCGAAA cctgagcggcctgcacttaaagccctatgacagga BcBOT4 homologuous 3′ region
K7Nat1 Fwd/Rev TAGAGCCGCATTCCCGATTCGG TGCAGGCCGCTCAGGGGCAGGG nourseothricin K7
BD52/BD12 gctacaggcggtggtatctc CTAAGGGCTCGCGGAGTTG BcBOT3 purity
BD52/Nat1Fverif gctacaggcggtggtatctc GACACCGCCCTGTACGAC BcBOT3 verif integration
BD2/BD13 cgcgggagaagtctctaagga gcttgaattcccagggatctg BcBOT4 purity
BD47/Nat1Fverif TCATTCACTCGAGCATACTTCC GACACCGCCCTGTACGAC BcBOT4 verif integration
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IR spectra were determined on a FT-IR spectrophotometer and
reported as wavenumber (cm−1).13
1H and 13C NMR spectra were obtained on Agilent 400 and 500
MHz spectrometers with SiMe4 as the internal reference at 25 °C.
13
Mass spectrometry (MS) and high resolution mass spectrometry
(HRMS) were performed on Thermoquest Voyager spectrometer and
QTOF mass spectrometer, respectively.13
bcbot3Δ Metabolite Analysis. Ten days after inoculation, the solid
agar malt medium was extracted32 yielding a dense oil from bcbot3Δ
culture (350 mg) that was separated by column chromatography on
silica gel, eluted with mixtures containing increasing percentages of
ethyl acetate/hexane (10−100%) and methanol as solvent.
Final puriﬁcation of selected fractions was carried out by HPLC
(hexane (Hex)−ethyl acetate (EtAc) 40:60; ﬂow 1 mL min−1). Three
compounds were isolated and characterized: 4β-acetoxy-15α-hydrox-
yprobotryane (2d) (39 mg), 4β-hydroxyprobotryan-15-ona (9) (1.1
mg), and botcinin A (6) (1.5 mg).
4β-Hydroxyprobotryan-15-one (9). Colorless oil; [α]D
25 = −9.62 (c
= 0.106 mg, CHCl3). IR υmax (ﬁlm) 3425.38, 2961.33, 1729.85,
1454.75, 913.80, 771.28 cm−1. 1H NMR (600 MHz, CDCl3), δ 4.04
(1H, ddd, J = 11.2, 9.6, 4.0 Hz, H-4), 2.69 (1H, dd, J = 18.1, 8.6 Hz, H-
10), 2.63 (1H, dd, J = 18.1, 3.3 Hz, H-10′), 2.13 (1H, d (br), H-7),
1.91 (1H, ddd, J= 12.8, 4.0, 2.9 Hz, H-3), 1.82 (1H, m, H-2), 1.64
(1H, ddd, J= 11.6, 8.6, 3.3 Hz, H-1), 1.46 (1H, d, J = 9.6 Hz, H-5),
1.37 (3H, s, H-14), 1.34 (3H, s, H-13), 1.32 (3H, s, H-12), 0.97 (3H,
d, J = 6.4 Hz, H-11). 13C NMR (151 MHz, CDCl3) δ 211.0 (s, C-15),
94.4 (s, C-9), 70.0 (d, C-4), 63.2 (s, C-8), 60.6 (d, C-5), 48.7 (d, C-1),
47.2 (s, C-6), 44.2 (t, C-7), 44.1 (t, C-3), 42.6 (t, C-10), 36.2 (q, C-
12), 33.4 (d, C-2), 27.8 (q, C-13), 23.9 (q, C-14), 21.0 (q, C-11).
HRMS (ES+) m/z calcd for C15H25O3 [M + H]
+ 253.1804, found
253.1807.
Acetylation of 4β-Hydroxyprobotryan-15-one (9). Compound 9
(5 mg) was dissolved in the minimum quantity of dry pyridine (0.5
mL), and acetic anhydride (30 mg) was added to the solution at 25
°C. The mixture was kept at RT for 24 h, and the solvent was
evaporated. The crude was chromatographed over silica gel (hexane−
ethyl acetate 8:2) and HPLC (Hex−EtAc) 80:20; ﬂow 1 mL min−1; tR
= 19.5 min) to give derivative 9a (4.5 mg).
4β-Acetoxyprobotryan-15-one (9a). Colorless oil; [α]D
25 = −9.40
(c = 0.1 mg, CHCl3); IR υmax (ﬁlm) 2350.4, 1727.5, 1248, 776.61,
669.12 470.26 cm−1. 1H NMR (600 MHz, benzene) δ 5.11 (1H, td, J
= 10.9, 4.0 Hz), 2.70 (1H, dd, J= 18.1, 8.6, Hz, H-10), 2.64 (1H, dd, J=
18.1, 3.4, Hz, H-10′), 2.17−2.08 (2H, m), 2.03 (3H, s, CH3COO−),
2.02 (1H, dt, J = 7.0, 5.4 Hz, H-3), 1.95 (1H, m, H-2), 1.37 (3H, d, J =
0.9 Hz), 1.29 (3H, s), 1.24 (2H, t, J = 3.6 Hz), 1.16 (3H, s), 1.23−1.01
(2H, m), 0.95 (3H, d, J = 6.4 Hz, H-11). 13C NMR (151 MHz,
CHCl3) δ 210.5 (s, C-15), 170.4 (s, CH3COO−), 94.0 (s, C-9), 72.2
(d, C-4), 63.1 (s, C-8), 56.2 (d, C-5), 48.6 (d, C-1), 47.15 (s, C-6),
44.1 (t, C-7), 42.7 (t, C-10), 39.6 (t, C-3), 35.8 (q, C-12), 33.2 (d, C-
2), 27.5 (q, C-13), 24.1 (q, C-14), 21.4 (CH3COO−), 20.9 (d, C-11).
HRMS (ES−) m/z calcd for C17H25O4 [M − H]− 293.1753, found
293.1779.
bcbot4Δ Metabolite Analysis. The analysis was carried out as
described for bcbot3Δ. Evaporation of the solvent under reduced
pressure aﬀorded a dense oil from the bcbot4Δ culture (360 mg) that
was chromatographed by CC on silica gel. Final puriﬁcation by HPLC
and GC-MS yielded the metabolite probotryane 2a and a signiﬁcant
number (15) of metabolites with polyketide skeletons. In addition to
the known polyketides the following were isolated and characterized:
botrylactone (3, 21.7 mg), botcinic and botcineric acids (4 and 5, 6.9
and 4.5 mg), botcinins A, B, E, and G (6, 7, 12, and 13, 63.6, 37.6,
10.1, and 7.9 mg), cinbotolide (8, 12 mg), acetylbotcinic and
acetylbotcineric acids (10 and 11, 8.3 and 7.0 mg), and 5-hydroxy-7-
(4-hydroxydec-2(3)-enoyl)botrylactone (14, 12.2 mg); the new
botrylactones, 5-hydroxy-7-(oct-2(3)-enoyl) botrylactone (15, 11.5
mg; semipreparative (Semprep) HPLC, Hex−EtAc−acetone (Act)
70:20:10; ﬂow 2.5 mL min−1; tR = 27 min) and 6-hydroxy-7-
deoxybotrylactone (16, 15 mg, semprep HPLC, Hex−EtAc−Act
70:20:10; ﬂow 2.5 mL min−1; tR = 38.5 min), and the new cinbotolides
B (17, 2.4 mg, semprep HPLC, Hex−EtAc−Act 50:40:10; ﬂow 2.5 mL
min−1; tR = 40 min) and C (18, 11.8 mg, semprep HPLC, Hex−EtAc
75:25; ﬂow 3 mL min−1; tR = 45 min).
Presilphiperfolan-8β-ol (Probotryane) (2a). The less polar fraction
obtained from the bcbot4Δ extract with hexane was studied by GC-
MS. Fermentations, for 4, 8, and 10 days, of wild-type B05.10 and of
the mutant bcbot4Δ were carried out, and the less polar fractions
obtained by extraction with hexane was studied by GC-MS. An
authentic sample of the presilphiperfolan-8β-ol (2a) was used as
reference to detect the compound in the extracts. Compound 2a was
not detected in the hexane fractions from the wild-type at 4, 8, and 10
days. However, the presence of compound 2a was clearly revealed in
all fractions from the fermentations of the mutant bcbot4Δ on diﬀerent
days (see Figure 5).
2R,3S,4S,6S,8R,9R-5-Hydroxy-7-(oct-2(3)-enoyl) botrylactone
(15). Yellow oil; [α]D
25 4.7 (c = 0.1 mg, CHCl3); IR υmax (ﬁlm)
3348, 2929.48, 1721.36, 1456.89, 1260.51, 1105.94, 1015.96, 719.49
cm−1. 1H NMR (400 MHz, CDCl3) δ 7.04 (1H, dt, J = 15.6, 6.9 Hz,
H-3′), 5.84 (1H, dt, J = 15.6, 1.6 Hz, H-2′), 4.93 (1H, d, J = 10.9 Hz,
H-7), 3.68 (1H, d(br), J = 11.1 Hz, H-5), 3.52 (1H, d, J = 0.5 Hz, H-
3), 2.76 (1H, qd, J = 7.4, 0.5 Hz, H-2), 2.21 (2H, m, H-4′), 1.97 (1H,
m, H-6), 1.55 (3H, s, C9−CH3), 1.47 (3H, d, J = 7.4 Hz, C2−CH3),
1.38−1.24 (m, H-5′, H-6′,H-7′), 1.15 (3H, s, C4−CH3), 1.10 (3H, s,
C8−CH3), 1.04 (3H, d, J = 6.5 Hz, C6−CH3), 0.90 (3H, t, J = 6.9 Hz,
H-8′). 13C NMR (100 MHz, CDCl3) δ 171.0 (s, C-1), 165.5 (s, C-1′),
151.4 (d, C-3′), 120.2 (d, C-2′), 104.2(s, C-9), 80.8 (d, C-3), 79.3 (d,
C-8), 76.2 (s, C-4), 75.2 (d, C-5), 73.8 (d, C-7), 36.5 (d, C-6), 34.5 (d,
C-2), 32.3(t, C-4′), 31.3 (t, C-5′), 27.6 (t, C-6)̀, 22.4 (t, C-7′), 21.7 (q,
C9−CH3), 18.5 (q, C2−CH3), 18.2 (q, C4−CH3), 18.1 (q, C8−CH3),
13.9 (q, C-8′), 13.8 (q, C6−CH3). HRMS (ES+) m/z calcd for
C22H35O7 [M + H]
+ 411.2383, found 411.2370.
6-Hydroxy-7-deoxybotrylactone (16). White amorphous powder;
[α]D
25 1.16 (c = 1.146 mg, CHCl3); IR υmax (ﬁlm) 3447.87, 2938.54,
1740.30, 1258.90, 1065.66, 976.23, 691.56 cm−1; 1H NMR (500 MHz,
CDCl3) δ 3.33 (1H, d, J = 0.7 Hz, H-3), 3.27 (1H, s(br), −OH), 2.74
(1H, qd, J = 7.3, 0.7 Hz, H-2), 1.91−1.69 (4H, m, H-5, H-7), 1.44
(3H, d, J = 7.3 Hz, C2−CH3), 1.44 (3H, s, C9−CH3), 1.30 (3H, s, C8−
CH3), 1.27 (3H, s, C4−CH3), 1.24 (3H, s, C6−CH3). 13C NMR (126
MHz, CDCl3) δ 171.1 (s, C-1), 104.4 (s, C-9), 81.6 (d, C-3), 76.5
(s,C-8), 72.8 (s, C-4), 70.3 (s, C-6), 45.0 (t, C-5), 43.1 (t,C-7), 34.4
(d, C-2), 28.2 (q, C6−CH3), 27.5 (q, C4−CH3), 26.4 (q, C8−CH3),
2206 (C9−CH3), 18.6 (q, C2−CH3). HRMS (ES−) m/z calcd for
C14H21O5 [M − H]− 269.1389, found 269.1385.
Cinbotolide B (17). Yellow oil; [α]D
25 −16.03 (c = 0.131 mg,
CHCl3); IR υmax (ﬁlm) 3417.83, 2925.61, 1747.89, 1455.50, 1383.58,
1217.32, 996.51, 934.66, 748.70 cm−1; 1H NMR (400 MHz, CDCl3) δ
5.39 (1H, q, J = 6.9 Hz, H-9), 4.15 (2H, dd, J = 12.0, 6.9 Hz, H-10),
4.05 (1H, d, J = 5.5 Hz, H-3), 2.94 (1H, dq, J = 7.3, 5.5 Hz, H-2), 2.26
(1H, dd(br), J = 13.1, 6.4 Hz, H-5), 2.02−1.75 (3H, m, H-5′, H-6, H-
7), 1.68 (3H, d, J = 6.9 Hz, C8−CH3), 1.71−1.6 (1H, m, H-7′), 1.36
(3H, s, C4−CH3), 1.24 (3H, d, J = 7.3 Hz, C2−CH3), 0.95 (3H, d, J =
6.2 Hz, C6−CH3). 13C NMR (100 MHz, CDCl3) δ 177.6 (s, C-1),
137.3 (s, C-8), 125.2 (d, C-9), 87.8 (s, C-4), 76.5 (d, C-3), 60.0 (t, C-
10), 44.5 (t, C-7), 40.7 (t, C-5), 40.0 (d, C-2), 27.2 (d, C-6), 23.2 (q,
C4−CH3), 21.4 (q, C6−CH3), 13.2 (q, C8−CH3), 8.3 (q, C2−CH3).
HRMS (ES+) m/z calcd for C14H25O4 [M + H]
+ 257.1747, found
257.1758.
Cinbotolide C (18). Colorless oil; [α]D
25 52.5 (c = 0.12 mg, CHCl3);
IR υmax (ﬁlm) 3426.45, 2926.73, 1752.33, 1643.35, 1456.46, 1046.65,
771.09 cm−1. 1H NMR (400 MHz, CDCl3) δ 4.18 (1H, d, J = 5.5 Hz,
H-3), 4.01 (2H, d, J = 1.3 Hz, H-12), 3.65 (1H, q, J = 6.5 Hz, H-9),
2.86 (1H, dq, J = 7.3, 5.5 Hz, H-2), 2.26 (1H, m, H-6), 1.78 (1H, ddd,
J = 14.5, 2.8, 1.6 Hz, H-5), 1.66 (1H,dd, J = 14.2, 11.4 Hz, H-7′), 1.57
(1H, dd, J = 14.5, 10.9 Hz, H-5′), 1.47 (1H, dt, J = 14.2, 1.7 Hz, H-7),
1.26 (3H, d, J = 7.3 Hz, C2−CH3), 1.21 (3H, s, C8−CH3), 1.14 (3H, d,
J = 6.5 Hz, C9−CH3), 0.98 (3H, d, J = 6.7 Hz, C6−CH3). 13C NMR
(100 MHz, CDCl3) δ 177.3 (s, C-1), 87.7 (s, C-8), 79.8 (s, C-4), 76.6
(d, C-3), 74.4 (d, C-9), 63.1 (t, C-12), 45.7 (t, C-5), 42.7(t, C-7), 39.7
(d, C-2), 24.6 (q, C6−CH3), 24.6 (d, C-6), 18.9 (q, C8−CH3), 17.3 (q,
C10-CH3), 8.3 (q, C2−CH3). HRMS (ES+) m/z calcd for C14H25O5
[M + H]+ 273.1702, found 273.1701.
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